Le Lézard
Classified in: Health
Subject: SVY

The global flow imaging microscopy market is projected to grow at a CAGR of 9.2%


LONDON, Oct. 15, 2018 /PRNewswire/ -- The global flow imaging microscopy market is projected to grow at a CAGR of 9.2%.
The global flow imaging microscopy market is projected to reach USD 49.23 million by 2023 from USD 31.67 million in 2018, at CAGR of 9.2% during the forecast period. Market growth is driven by benefits of flow imaging microscopy over other particle analyzers. Recommendations for pharmaceutical and biopharmaceutical quality control and increasing investments in pharmaceutical and biopharmaceutical R&D are also expected to support market growth. The technological limitations of flow imaging microscopy are expected to hinder market growth to a certain extent.

Download the full report: https://www.reportbuyer.com/product/5589887

Biotechnology companies are estimated to dominate the flow imaging microscopy market in 2018.
By end user, the flow imaging microscopy market is divided into biotechnology companies, pharmaceutical companies, and other end users.In 2018, biotechnology companies are estimated to be the largest end users of flow imaging microscopy.

This is because the demand for flow imaging microscopy is high in biotechnology companies owing to the significant impact of particle sizes on the safety and efficacy of biologics.

The biologics segment is estimated to account for the largest share of the market in 2018.
On the basis of sample type, the flow imaging microscopy market is divided into biologics, small molecules, and other sample types.Biologics are expected to dominate the market in 2018 as well as register the highest growth rate during the forecast period.

Regulatory recommendations for subvisible particle analysis in biologics and better suitability of flow imaging microscopy are the major factors contributing to market growth.

The wet dispersion segment is estimated to dominate the market in 2018.
Based on sample dispersion, the flow imaging microscopy market is divided into wet dispersion and dry dispersion.The wet dispersion segment is expected to dominate the market in 2018 as well as register the highest CAGR during the forecast period.

The wide adoption of wet dispersion for biologics, which is a major application area of flow imaging microscopy, is a major factor contributing to market growth.

North America is estimated to account for the largest share of the market in 2018.
By geography, North America is estimated to account for the largest share of the flow imaging microscopy market in 2018, followed by Europe. The well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, and high R&D investments in North America are the key drivers for this regional market.

Break-up profile of primaries:
? By Company Type - Tier 1-42%, Tier 2 - 37%, and Tier 3 - 21%
? By Designation - C-level - 34%, D-level - 42%, and Others - 24%
? By Region - North America - 32%, Europe - 30%, Asia Pacific - 24%, and RoW -14%

The key players operating in the flow imaging microscopy market are ProteinSimple (US), Fluid Imaging Technologies (US), Occhio (Belgium), and Fritsch (Germany).

Research Coverage:
The flow imaging microscopy market in this report is segmented by sample type, sample dispersion, and end user.The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions.

It also profiles key players and their core competencies in the flow imaging microscopy market.

Reasons to buy this report:

The report provides insights on the following pointers:
? Market Penetration: Comprehensive information on the portfolios offered by top players in the flow imaging microscopy market
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global flow imaging microscopy market
? Market Development: Comprehensive information about lucrative emerging markets?the report analyzes markets for flow imaging microscopy products across regions
? Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the market
? Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global flow imaging microscopy market

Download the full report: https://www.reportbuyer.com/product/5589887

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: